{"nct_id":"NCT02852837","title":"Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic Therapy","status":"COMPLETED","status_verified_date":"2020-11","start_date":"2016-09-26","start_date_type":"ACTUAL","primary_completion_date":"2019-12-13","primary_completion_date_type":"ACTUAL","completion_date":"2019-12-13","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["JNJ"]}